Los Angeles Capital Management’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-31,366
| Closed | -$1.21M | – | 1192 |
|
|
2024
Q4 | $1.21M | Buy |
31,366
+8,920
| +40% | +$344K | ﹤0.01% | 562 |
|
|
2024
Q3 | $1.01M | Sell |
22,446
-8,381
| -27% | -$377K | ﹤0.01% | 652 |
|
|
2024
Q2 | $1.07M | Hold |
30,827
| – | – | ﹤0.01% | 636 |
|
|
2024
Q1 | $892K | Buy |
30,827
+21,673
| +237% | +$627K | ﹤0.01% | 726 |
|
|
2023
Q4 | $210K | Buy |
+9,154
| New | +$210K | ﹤0.01% | 1088 |
|
|
2023
Q3 | – | Sell |
-9,366
| Closed | -$259K | – | 1214 |
|
|
2023
Q2 | $259K | Sell |
9,366
-36,107
| -79% | -$997K | ﹤0.01% | 1053 |
|
|
2023
Q1 | $1.05M | Sell |
45,473
-31,517
| -41% | -$725K | ﹤0.01% | 652 |
|
|
2022
Q4 | $840K | Hold |
76,990
| – | – | ﹤0.01% | 750 |
|
|
2022
Q3 | $649K | Buy |
76,990
+6,060
| +9% | +$51.1K | ﹤0.01% | 843 |
|
|
2022
Q2 | $561K | Buy |
+70,930
| New | +$561K | ﹤0.01% | 925 |
|
|
2021
Q2 | – | Sell |
-47,387
| Closed | -$1.23M | – | 1652 |
|
|
2021
Q1 | $1.23M | Sell |
47,387
-620
| -1% | -$16.1K | 0.01% | 804 |
|
|
2020
Q4 | $968K | Buy |
48,007
+1,300
| +3% | +$26.2K | ﹤0.01% | 957 |
|
|
2020
Q3 | $913K | Hold |
46,707
| – | – | ﹤0.01% | 857 |
|
|
2020
Q2 | $825K | Buy |
46,707
+17,590
| +60% | +$311K | ﹤0.01% | 920 |
|
|
2020
Q1 | $206K | Buy |
+29,117
| New | +$206K | ﹤0.01% | 1168 |
|